Piedmont Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,909
| Closed | -$861K | – | 30 |
|
|
2020
Q1 | $861K | Buy |
7,909
+1,223
| +18% | +$133K | 0.03% | 325 |
|
|
2019
Q4 | $770K | Buy |
6,686
+113
| +2% | +$13K | 0.03% | 394 |
|
|
2019
Q3 | $529K | Buy |
6,573
+38
| +0.6% | +$3.06K | 0.02% | 496 |
|
|
2019
Q2 | $474K | Buy |
6,535
+417
| +7% | +$30.2K | 0.02% | 568 |
|
|
2019
Q1 | $572K | Buy |
6,118
+371
| +6% | +$34.7K | 0.02% | 464 |
|
|
2018
Q4 | $419K | Buy |
5,747
+22
| +0.4% | +$1.6K | 0.02% | 532 |
|
|
2018
Q3 | $501K | Buy |
5,725
+5,721
| +143,025% | +$501K | 0.02% | 515 |
|
|
2018
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2875 |
|